Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
-
GDEV Aligns Leadership as Founder and CEO Andrey Fadeev Appointed Chairperson of the Board
-
ZenaTech’s ZenaDrone Subsidiary Develops and Tests Proprietary Drone Communications System Enabling Secure and Reliable Communications for US Defense Applications
-
GraniteShares launches new leveraged ETFs on Intel, Dell and Qualcomm
-
LiveOne (Nasdaq: LVO) Reports Record 9-Month Revenues of $95.1M
-
Locafy Introduces Localizer, a Powerful Solution to Boost Local Search Visibility and Drive Partner-Led Growth
-
AgEagle Aerial Systems Announces eBee is the Most Used Conventional Fixed Wing Drone for U.S. Commercial Operators Based on Federal Aviation Administration (FAA) Registration Data
-
Expand Energy Corporation Appoints Dan Turco Executive Vice President, Marketing & Commercial
-
Webuy Global Ltd. Provides Update on Nasdaq Listing and Strategic Growth Initiatives
-
Flirting with Fraud: Why Sextortion Is the Most Devastating Dating Scam
-
Economic Conditions Mount Supporting “Peak Truck” as Trend to Watch in 2025, as Identified in Dave Cantin Group’s Market Outlook Report
-
PodcastOne (NASDAQ: PODC) and Kailyn Lowry Extend Podcast Production Partnership with KILLR Network Podcast Renewals, Surpass 50 Million Total Downloads
-
Incyclix Bio Announces Publication in Nature Communications Highlighting Biomarkers of Response to CDK2 Inhibition
-
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
-
Flock Safety Reveals the Most Expansive AI and Data Analysis Toolset for Law Enforcement, Including Flock Nova, A New Platform To Transform Investigations
-
New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
-
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
-
Foremost Clean Energy to Attend Prospectors & Developers Association of Canada (PDAC) 2025 Convention
-
1m Launches Risk Intelligence Network to Help Healthcare Providers Respond to Federal Policy Changes
-
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025
-
Loadsmart Launches a Yard Management System (YMS) to Connect Dock and Yard Operations
-
Dallas Wings Partners with TEGNA’s KFAA for Broadcast Rights Agreement
-
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimer’s Disease
-
Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit
-
GLMX and FlexTrade Announce a Strategic Collaboration to Deliver Seamless Trading and Enhanced Workflows
-
Magnite to Participate in the Susquehanna Financial Group 14th Annual Technology Conference
-
FormAssembly Appoints Lou Ponticas to Board of Directors and Welcomes Tom Urie as President and Chief Operating Officer
-
Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
-
red violet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
-
Counslr Launches in New Mexico and Illinois; Expands Footprint in New York to Increase Access to Mental Health Support
-
Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
-
Notice of the Annual General Meeting of Nokia Corporation
-
Arbitral tribunal appointed for the arbitration proceedings concerning the redemption of minority shares in Innofactor Plc
-
WhiteBIT Freezes Over $150M: How the Exchange is Fighting Crypto Crime
-
Form 8.3 - [ALLIANCE PHARMA PLC - 12 02 2025] - (CGWL)
-
New Study Busts 5 Common Myths About Kosher Travel: Findings from TotallyJewishTravel.com Reveal the Expanding World of Kosher Vacations
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 12 02 2025] - (CGWL)
-
Brunswick Corporation Declares Quarterly Dividend
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 11 02 2025] - (CGWL) - CORRECTION
-
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
-
Robex Announces Approval of the New Convention by the Government of Mali
-
Bitget Lists Story Protocol (IP) with Exclusive Launchpool Rewards and Spot Trading
-
Kean University Earns Prestigious R2 Research Designation
-
Abaxx Will Expand Battery Metals Product Suite with Launch of Lithium Carbonate Futures on March 7, 2025
-
Kelly Reports Fourth-Quarter and Full-Year 2024 Earnings
-
Prime Drink Group Announces Its Intention to Unlock the Value of Its Quebec Water Assets
-
Unicorn Co-Founder Mark Wendou Niu Joins YY Group as Chief Strategist Officer
-
center3 and Zoom partner for node deployment enhancing regional user experience
-
Bitget's Protection Fund Average Hits $648M in January 2025
-
Bitget's Protection Fund Average Hits $648M in January 2025
